• Wondering if Aflac at around US$112 per share is offering fair value or a potential mispricing opportunity today? This article breaks down what the current market price might be signaling.
• The stock is up 2.0% year to date and 10.9% over the past year, with longer term returns of 80.0% over three years and 119.2% over five years, even though the price has declined 4.6% in the last week and 3.3% over the past month.
• Recent coverage has focused on Aflac as an established insurance company, with attention on how investors weigh its stability against changing interest rate expectations and sector sentiment. This context helps frame the shorter term pullback within a longer track record that many investors follow closely.
• Aflac currently has a valuation score of 3/6. The next sections will walk through how common methods like P/E comparisons and cash flow based models assess the stock, before finishing with a broader way to think about what valuation really means for your portfolio decisions.

Approach 1: Aflac Excess Returns Analysis

The Excess Returns model looks at how efficiently Aflac turns shareholder capital into profits, then compares those returns with the cost of that capital. In simple terms, it asks whether the company earns more on its equity than investors require, and how long that can reasonably continue.

For Aflac, the model uses a Book Value of $58.69 per share and a Stable EPS of $8.15 per share, based on weighted future Return on Equity estimates from 5 analysts. The Average Return on Equity is 13.38%, while the Cost of Equity is $4.33 per share. That gap produces an Excess Return of $3.82 per share, which is then applied to a Stable Book Value of $60.91 per share, sourced from 8 analysts, to estimate long term value creation.

This approach results in an estimated intrinsic value of about $168.02 per share. Compared with the current share price around $112, the Excess Returns model implies the stock is around 33.1% undervalued.

Result: UNDERVALUED

Our Excess Returns analysis suggests Aflac is undervalued by 33.1%. Track this in your watchlist or portfolio, or discover 46 more high quality undervalued stocks.

Approach 2: Aflac Price vs Earnings

For a profitable company like Aflac, the P/E ratio is a useful shorthand for how much you are paying for each dollar of earnings. It connects directly to what the business is currently earning, which makes it easier to relate the share price to the underlying profit stream.

What counts as a “normal” P/E depends on how investors view a company’s growth potential and risk. Higher expected growth or lower perceived risk can justify a higher multiple, while slower expected growth or higher risk usually lines up with a lower one.

Aflac trades on a P/E of 12.34x. That sits above the broader Insurance industry average of 10.71x, but below the peer group average of 14.26x. Simply Wall St also estimates a “Fair Ratio” of 9.64x for Aflac. This Fair Ratio is a proprietary metric that reflects factors such as Aflac’s earnings growth profile, industry, profit margins, market cap and risk characteristics, rather than just taking a simple peer or sector average.

Because the Fair Ratio incorporates these fundamentals, it can be more tailored than straight comparisons. On this basis, Aflac’s current 12.34x P/E is higher than the 9.64x Fair Ratio, suggesting the stock may be trading above that model’s implied level.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Aflac Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St let you attach a clear story about Aflac to the numbers by linking your view of its future revenue, earnings and margins to a financial forecast, a fair value, and then a simple comparison with the current share price. All of this is available within an easy tool on the Community page that updates as new news or earnings arrive. One investor might build a more optimistic Aflac Narrative closer to the US$126 price target, while another might build a more cautious one nearer US$99, and both can use those fair values against today’s price to decide whether the stock currently looks attractive or expensive for their own portfolio goals.

Do you think there's more to the story for Aflac? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.